English
Regional settings| Spread | 0.15 | ||||
 Long position overnight feeLong position overnight fee
Trade size with leverage ~ HK$5,000.00 Short position overnight fee ~ HK$4,000.00 | -0.021963% | ||||
| Short position overnight fee Short position overnight fee
Trade size with leverage ~ HK$5,000.00 Short position overnight fee ~ HK$4,000.00 | 0.000045% | ||||
| Overnight fee time | 21:00 (UTC) | ||||
| Currency | HKD | ||||
| Min traded quantity | 1 | ||||
| Margin | 20 | ||||
| Stock exchange | Hong Kong | ||||
| Commission on trade1 | 0% |
Information_provided_by_capital
1Our charge for executing your trade is the spread, the difference between the buy and sell price. Please consult the Charges and Fees section of our website for further information
| Prev. Close | 21.7 |
| Open | 21.7 |
| 1-Year Change | -19.03% |
| Day's Range | 21.35 - 21.85 |
Sinopharm Group Co Ltd is a China-based company principally engaged in pharmaceutical and medical devices distribution business. The Company operates its business through four segments. Pharmaceutical Distribution segment is engaged in the distribution of pharmaceutical products to hospitals, other distributors, retail pharmacy stores and clinics. Medical Devices segment is engaged in the distribution of medical devices, as well as provides installation and maintenance services. Retail Pharmacy segment is engaged in the operation of chain pharmacy stores. Other Business segment is engaged in the distribution of laboratory supplies, manufacture and distribution of chemical reagents, production and sale of pharmaceutical products.
BRIEF: For the fiscal year ended 31 December 2021, SINOPHARM HOLDING CO LTD revenues increased 14% to RMB521.05B. Net income applicable to common stockholders increased 8% to RMB7.76B. Revenues reflect Retail Sales - Total increase of 20% to RMB28.57B. Net income was partially offset by Impairment of Intangibles increase from RMB265M to RMB606.9M (expense), Bank and other borrowings increase of 10% to RMB2.87B (expense).
